Skip to main content

Table 1 Characteristics of study participants

From: Enhancing the uptake of systematic reviews of effects: what is the best format for health care managers and policy-makers? A mixed-methods study

 

n/%

 

Phase 1

Phase 2

Phase 3

(n = 12)

Characteristicsa

Survey

(n = 202)

Interview (n = 11)

Round 1

(n = 13)

Round 2

(n = 21)

Professional role

 Health care manager

80 (39.6)

5 (45.5)

5 (38.5)

9 (42.9)

5 (41.7)

 Policy-maker/advisor/analyst

122 (60.4)

6 (54.5)

8 (61.5)

12 (57.1)

7 (58.3)

Provinces

 Alberta

39 (19.3)

3 (27.3)

1 (7.7)

3 (14.3)

3 (25.0)

 British Columbia

71 (35.1)

2 (18.2)

5 (38.5)

8 (38.1)

3 (25.0)

 Ontario

83 (41.1)

6 (54.5)

7 (53.8)

9 (42.9)

6 (50.0)

 Quebec

9 (4.4)

0 (0.0)

0 (0.0)

1 (4.8)

0 (0.0)

Years of experience in role

 1

12 (5.9)

0 (0.0)

1 (7.7)

2 (9.5)

2 (16.7)

 2–10

88 (43.6)

7 (63.6)

9 (69.2)

9 (42.9)

2 (16.7)

 11–20

59 (29.2)

4 (36.4)

3 (23.1)

8 (38.1)

6 (50.0)

 20+

43 (21.3)

0 (0.0)

0 (0.0)

2 (9.5)

2 (16.7)

Level of organization

 National

8 (4.0)

1 (9.1)

2 (15.4)

2 (9.5)

1 (8.3)

 Provincial

136 (67.3)

9 (81.8)

10 (76.9)

15 (71.4)

8 (66.7)

 Regional

34 (16.8)

0 (0.0)

0 (0.0)

1 (4.8)

2 (16.7)

 Local

24 (11.9)

1 (9.1)

1 (7.7)

3 (14.3)

1 (8.3)

Description of organization

 Health service provider

92 (45.5)

5 (45.5)

5 (38.5)

10 (47.6)

6 (50.0)

 Government agency

73 (36.1)

2 (18.2)

3 (23.1)

6 (28.6)

4 (33.3)

 Funding agency

1 (0.5)

0 (0.0)

0 (0.0)

0 (0.0)

0 (0.0)

 Not for profit

3 (1.5)

0 (0.0)

0 (0.0)

0 (0.0)

0 (0.0)

 Other

33 (16.3)

4 (36.4)

5 (38.5)

5 (23.8)

2 (16.7)

Geographic location

 Urban

176 (87.1)

11 (100.0)

13 (100.0)

20 (95.2)

12 (100.0)

 Suburban

13 (6.4)

0 (0.0)

0 (0.0)

1 (4.8)

0 (0.0)

 Rural

13 (6.4)

0 (0.0)

0 (0.0)

0 (0.0)

0 (0.0)

Training on interpreting systematic reviews

 Yes

111 (55.0)

7 (63.3)

9 (69.2)

13 (61.9)

8 (66.7)

 No

91 (45.9)

4 (36.4)

4 (30.8)

8 (38.1)

4 (33.3)

Use of systematic reviews

 Never

37 (18.3)

1 (9.1)

0 (0.0)

2 (9.5)

0 (0.0)

 Once

27 (13.7)

2 (18.2)

2 (15.4)

3 (14.3)

1 (8.3)

 Every 2–3 months

53 (26.2)

4 (36.4)

6 (46.2)

6 (28.6)

3 (25.0)

 Once a month

33 (16.3)

2 (18.2)

1 (7.7)

2 (9.5)

1 (8.3)

 Twice a month

22 (10.9)

1 (9.1)

0 (0.0)

1 (4.8)

2 (16.7)

 Once a week

18 (8.9)

0 (0.0)

2 (15.4)

2 (9.5)

1 (8.3)

 Every day

12 (5.9)

1 (9.1)

2 (15.4)

5 (23.8)

4 (33.3)

  1. aNote: a sequential sampling approach was used to recruit participants throughout the three phases of this study. Therefore, participants may appear in one or more phases of the study